Saturday 25 April 2026

12:20-13:20 CEST Sala d’Assaig

Kyowa Kirin

Advancing XLH care with the latest evidence across the lifespan

12:20 – 12:35 Welcome and introductions: Exploring the foundations of bone mineralisation
Lothar Seefried

12:35 – 12:50 Harnessing real-world experiences to enhance HRQoL outcomes in adolescents living with XLH

Vrinda Saraff

12:50 – 13:05 Leveraging the latest research to optimise treatment and support adults living with XLH

Richard Keen

13:05 – 13:15 Q&A
All faculty

13:15 – 13:20 Summary and close
Lothar Seefried

13:30-14:30 CEST Sala Petita

Theramex

Targeting bone formation: clinical insights with abaloparatide

13:30 – 13:40 Anabolic therapy in osteoporosis: when bone quality matters
Xavier Nogués

13:40 – 14:00 Cortical bone gains with abaloparotide: clinical experience from practice

Heide Siggelkow

14:00 – 14:20 Early use of anabolic therapy in osteoporosis management
Richard Keen

14:20 – 14:25 Abaloparatide in context: mechanism, timing and clinical confidence
Xavier Nogués

14:24 – 14:30 Q&A
Xavier Nogués

17:00-17:30 CEST Sala 1

Bruker Biospin GmbH

Bruker microCT: 3D Insights into Bone and Calcified Tissues

17:00 – 17:30 Bruker microCT: 3D Insights into Bone and Calcified Tissues
Fahimeh Azari

Sunday 26 April 2026

13:00-14:00 CEST Sala Petita

Gedeon Richter

Brothers in arms against osteoporosis: the roles of RANKL and PTHR / Managing challenging clinical cases

Experts: Lothar Seefried, Serge Ferrari

16:30-17:00 CEST Sala 1

Qiagen GmbH

From Uninformative Samples to Actionable Evidence: The Clinical Value of NGS-Based Kinship Analysis in Challenging Human Bone Remains

16:30-16:45 From Uninformative Samples to Actionable Evidence: The Clinical Value of NGS-Based Kinship Analysis in Challenging Human Bone

Polyzois Makras

16:45-17:00 From Soil to Sequence: Navigating Bone Degradation in Spanish Civil War Remains through MPS Technology

Isabel Navarro Vera